Standout Papers
- Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease (2006)
- Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus (1988)
- A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema (2005)
- RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW (2004)
Immediate Impact
9 by Nobel laureates 26 from Science/Nature 79 standout
Citing Papers
Development of Better Aptamers: Structured Library Approaches, Selection Methods, and Chemical Modifications
2024 Standout
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Works of Emmett T. Cunningham being referenced
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Emmett T. Cunningham | 3708 | 785 | 305 | 1925 | 1242 | 144 | 8.4k | |
| Jonathan Kipnis | 431 | 865 | 223 | 3880 | 471 | 163 | 19.6k | |
| Denis Wakefield | 3099 | 683 | 1352 | 1216 | 2825 | 263 | 11.4k | |
| Joseph Herbert | 157 | 379 | 659 | 2041 | 988 | 113 | 7.8k | |
| Alessandra Micera | 1011 | 146 | 170 | 920 | 1118 | 148 | 4.5k | |
| Jan Bauer | 289 | 1210 | 1037 | 3387 | 828 | 217 | 14.1k | |
| Russell N. Van Gelder | 2469 | 547 | 599 | 2922 | 498 | 159 | 7.9k | |
| Russell C. Dale | 329 | 1678 | 1746 | 1788 | 252 | 291 | 13.1k | |
| Darlene A. Dartt | 1898 | 131 | 144 | 1761 | 2211 | 227 | 7.7k | |
| Daniel J.J. Carr | 442 | 2554 | 276 | 1772 | 430 | 201 | 6.5k | |
| Richard D. Unwin | 2306 | 261 | 250 | 2255 | 1722 | 143 | 5.6k |
All Works
Loading papers...